<owl:Class xmlns="https://folio.openlegalstandard.org/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:v1="http://www.loc.gov/mads/rdf/v1#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:folio="https://folio.openlegalstandard.org/" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:skos="http://www.w3.org/2004/02/skos/core#" rdf:about="https://folio.openlegalstandard.org/R7lCj2dvGu7618ONPPEpJB">
  <rdfs:subClassOf rdf:resource="https://folio.openlegalstandard.org/RBJ0dgV4Z2Xk7aGfJt2nSj7"/>
  <rdfs:label>Systemic Sclerosis</rdfs:label>
  <skos:altLabel>Autoimmune Connective Tissue Disorder</skos:altLabel>
  <skos:altLabel>Progressive Systemic Sclerosis</skos:altLabel>
  <skos:prefLabel>Scleroderma</skos:prefLabel>
  <skos:definition>Systemic sclerosis (also known as scleroderma) constitutes a spectrum of disease in which thickening of the skin is the clinical hallmark. Raynaud's phenomenon, often medically severe and progressive, is present frequently and may be the peripheral manifestation of a vasospastic abnormality in the heart, lungs, and kidneys. The CREST syndrome (calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia) is a variant that may slowly progress over years to the generalized process, systemic sclerosis.</skos:definition>
</owl:Class>
